AptarGroup Newsroom

AptarGroup Is Maintained at Outperform by Raymond James

Dow JonesApr 22 13:14 ET

AptarGroup Analyst Ratings

BenzingaApr 22 13:05 ET

Raymond James Maintains AptarGroup(ATR.US) With Buy Rating, Cuts Target Price to $175

Moomoo NewsApr 22 08:32 ET

William Blair Initiates AptarGroup(ATR.US) With Buy Rating

Moomoo NewsApr 16 00:31 ET

Analysts Conflicted on These Healthcare Names: Outset Medical (OM) and AptarGroup (ATR)

TipRanksApr 15 21:55 ET

BofA Securities Maintains AptarGroup(ATR.US) With Hold Rating, Maintains Target Price $173

Moomoo NewsFeb 28 07:37 ET

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), BeiGene (ONC) and AptarGroup (ATR)

TipRanksFeb 24 08:34 ET

DBS Maintains AptarGroup(ATR.US) With Buy Rating, Cuts Target Price to $175

Moomoo NewsFeb 24 08:33 ET

AptarGroup Price Target Cut to $190.00/Share From $200.00 by Raymond James

Dow JonesFeb 10 11:32 ET

Raymond James Reiterates Outperform on AptarGroup, Lowers Price Target to $190

BenzingaFeb 10 11:22 ET

AptarGroup Is Maintained at Overweight by Wells Fargo

Dow JonesFeb 10 09:58 ET

AptarGroup: Strong Q4 Performance and Promising Long-Term Outlook Support Buy Rating

TipRanksFeb 10 08:57 ET

Baird Maintains AptarGroup(ATR.US) With Buy Rating, Cuts Target Price to $160

Moomoo NewsFeb 10 08:33 ET

AptarGroup Is Maintained at Outperform by Baird

Dow JonesFeb 10 08:23 ET

AptarGroup Analyst Ratings

BenzingaFeb 10 08:13 ET

Wells Fargo Maintains AptarGroup(ATR.US) With Buy Rating, Cuts Target Price to $170

Moomoo NewsFeb 10 07:31 ET

Wells Fargo Maintains AptarGroup(ATR.US) With Buy Rating, Maintains Target Price $180

Moomoo NewsFeb 7 06:31 ET

AptarGroup's Strong Q4 2024 Performance and Positive 2025 Outlook Justifies Buy Rating

TipRanksFeb 7 06:15 ET

AptarGroup Initiated at Outperform by Raymond James

Dow JonesJan 7 07:12 ET

Raymond James Maintains AptarGroup(ATR.US) With Buy Rating, Maintains Target Price $200

Moomoo NewsJan 7 05:34 ET